Bafna Pharmaceuticals reports standalone net profit of Rs 0.95 crore in the December 2024 quarter
Sales rise 16.70% to Rs 33.19 crore
Net profit of Bafna Pharmaceuticals reported to Rs 0.95 crore in the quarter ended December 2024 as against net loss of Rs 2.94 crore during the previous quarter ended December 2023. Sales rose 16.70% to Rs 33.19 crore in the quarter ended December 2024 as against Rs 28.44 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales33.1928.44 17 OPM %9.25-7.28 -PBDT2.62-1.67 LP PBT0.96-2.94 LP NP0.95-2.94 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content